Look at it this way. I have zero clue how First Berlin analyst guessed at 7 cents per share in 2027. I didn’t read anything past that in the report. I do not have much of a clue about revenue or COGS. They haven’t told anyone. Assuming this is a high growth stock for all solid cancer the 7 cents would at least get a 20 multiple. And total revenue at this point could get a 20 multiple. So, we will be over $1. Depending on what forward guidance is given.
Market Data 
Markets 
AI
